ARESTIN Periodontal Disease Treatment from OraPharma, Inc.

ARESTIN Periodontal Disease Treatment

Share this product with your colleagues

Description

ARESTIN (minocycline hydrochloride) is indicated as an adjunct to scaling and root planing (SRP) procedures for reduction of pocket depth in patients with adult periodontitis. Using advanced microsphere technology, ARESTIN releases its medicine over time to kill the bacteria that help cause periodontitis. Currently, ARESTIN is the leading locally administered antibiotic for the treatment of periodontitis.

Not Available

from
OraPharma, Inc. for
ARESTIN Periodontal Disease Treatment

Compare All Related

ATRIDOX Periodontal Disease Treatment from DenMat

select to compare

Product Details
Company Info
Videos

Product Specs
ItemARESTIN Periodontal Disease Treatment
CompanyOraPharma, Inc.
PriceNot Available
Catalog Number125
QuantityBox - 2 Resealable Pouches
Pouch - 12 Unit-Dose Cartridges
Cartridge - 1 mg of Minocycline HCI
Resorption Time21 days
Delivery MethodCartridge
Warnings or ContraindicationsContraindications
Arestin should not be used in any patient who has a known sensitivity to minocycline or tetracyclines.
Warnings
The use of drug of the tetracycline class during tooth development (last half of pregnancy, infancy, and childhood to the age of 8 years) may cause permenent discoloration of the teeth and in pregnent or nursing women, unless the potential benifits are considered to outweigh the potential risks.
Antibiotic / Antimicrobial CompositionMinocycline HCl
Self ResorbingYes
Preplacement TreatmentPlace In Deep Gum Pockets